Browsing by Author "Dr. D.Y. Patil Medical College, Navi Mumbai"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    PublicationMetadata only
    The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
    (2018-07-01) T. Zuberbier; W. Aberer; R. Asero; A. H. Abdul Latiff; D. Baker; B. Ballmer-Weber; J. A. Bernstein; C. Bindslev-Jensen; Z. Brzoza; R. Buense Bedrikow; G. W. Canonica; M. K. Church; T. Craig; I. V. Danilycheva; C. Dressler; L. F. Ensina; A. Giménez-Arnau; K. Godse; M. Gonçalo; C. Grattan; J. Hebert; M. Hide; A. Kaplan; A. Kapp; C. H. Katelaris; E. Kocatürk; K. Kulthanan; D. Larenas-Linnemann; T. A. Leslie; M. Magerl; P. Mathelier-Fusade; R. Y. Meshkova; M. Metz; A. Nast; E. Nettis; H. Oude-Elberink; S. Rosumeck; S. S. Saini; M. Sánchez-Borges; P. Schmid-Grendelmeier; P. Staubach; G. Sussman; E. Toubi; G. A. Vena; C. Vestergaard; B. Wedi; R. N. Werner; Z. Zhao; M. Maurer; Humanitas University; Saǧlik Bakanliǧi Okmeydani Eǧitim ve Araştirma Hastanesi; CHU de Québec - Université Laval; State Research Center Institute of Immunology FMBA; Universidade de Coimbra, Faculdade de Medicina; The Johns Hopkins Asthma and Allergy Center; Hiroshima University; NHS Foundation Trust; Bnai-Zion Medical Center; Slaski Uniwersytet Medyczny w Katowicach; Centro Medico Docente La Trinidad; Charité – Universitätsmedizin Berlin; University of Cincinnati; Medizinische Hochschule Hannover (MHH); Ârhus Universitetshospital; Medical University of South Carolina; Universitat Autònoma de Barcelona; Università degli Studi di Bari; UCL; Klinikum der Johannes-Gutenberg-Universität und Fachbereich Medizin; Syddansk Universitet; Western Sydney University; University of Toronto; Universidade Federal de Sao Paulo; Peking University; Hopital Tenon; Penn State Health Milton S. Hershey Medical Center; Faculty of Medicine, Siriraj Hospital, Mahidol University; Pantai Holdings Sdn Bhd; University of Groningen; University Hospital Zurich, Dermatologische Klinik; Medizinische Universität Graz; Smolensk State Medical Academy; Dr. D.Y. Patil Medical College, Navi Mumbai; Baker Allergy Asthma Dermatology Research Center, LLC; Dermatology and Venereology Private Practice; Santa Casa de São Paulo School of Medical Sciences; Hospital Médica Sur; Clinica San Carlo
    © 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
  • No Thumbnail Available
    PublicationMetadata only
    Recommendations for the adjuvant use of the poly-antibiotic–resistant probiotic Bacillus clausii (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts
    (2020-12-01) Jo Anne De Castro; Dhanasekhar Kesavelu; Keya Rani Lahiri; Nataruks Chaijitraruch; Voranush Chongsrisawat; Pramod Prabhakar Jog; Yun Haw Liaw; Gia Khanh Nguyen; Thi Viet Ha Nguyen; Uday Ananth Pai; Huu Nguyet Diem Phan; Seng Hock Quak; Pornthep Tanpowpong; Mary Jean Guno; De La Salle Medical and Health Sciences Institute; Dr. D. Y. Patil Medical College, Hospital & Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune; University of Medicine and Pharmacy Vietnam; Hanoi Medical University; National University Hospital, Singapore; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Dr. D.Y. Patil Medical College, Navi Mumbai; Institute of Pediatrics; Pai’s Clinic; KPJ Sabah Specialist Hospital; Apollo Children's Hospital; Vietnam Aerospace Association
    © 2020, The Author(s). This paper proposes recommendations for probiotics in pediatric gastrointestinal diseases in the Asia-Pacific region. Evidence-based recommendations and randomized controlled trials in the region are included. Cultural aspects, health management issues and economic factors were also considered. Final recommendations were approved by utilizing a modified Delphi process and applying the Likert scale in an electronic voting process. Bacillus clausii was recommended as an adjunct treatment with oral rehydration solution for acute viral diarrhea. B. clausii may also be considered for prevention of antibiotic-associated diarrhea, Clostridium difficile-induced diarrhea, and as adjunct treatment of Helicobacter pylori. There is insufficient evidence for recommendations in other conditions. Despite a diversity of epidemiological, socioeconomical and health system conditions, similar recommendations currently apply to most Asia-Pacific countries. Ideally, these need to be validated with local randomized-controlled trials.